Next Article in Journal
Stationary External Electric Field—Mimicking the Solvent Effect on the Ground-State Tautomerism and Excited-State Proton Transfer in 8-(Benzo[d]thiazol-2-yl)quinolin-7-ol
Previous Article in Journal
Schiff Bases Derived from Pyridoxal 5′-Phosphate and 2-X-Phenylamine (X = H, OH, SH): Substituent Effects on UV-Vis Spectra and Hydrolysis Kinetics
Previous Article in Special Issue
P(V)-Promoted Rh-Catalyzed Highly Regioselective Hydroformylation of Styrenes under Mild Conditions
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 29
Issue 15
10.3390/molecules29153505
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pallado-Catalyzed Cascade Synthesis of 2-Alkoxyquinolines from 1,3-Butadiynamides

by
Illia Lenko
,
Alexander Mamontov
,
Carole Alayrac
* and
Bernhard Witulski
*
Laboratoire de Chimie Moléculaire et Thio-organique (LCMT), CNRS UMR 6507, ENSICAEN & UNICAEN, Normandie University, 6 Bd Maréchal Juin, 14050 Caen, France
*
Authors to whom correspondence should be addressed.
Molecules 2024, 29(15), 3505; https://doi.org/10.3390/molecules29153505
Submission received: 25 June 2024 / Revised: 23 July 2024 / Accepted: 24 July 2024 / Published: 26 July 2024
(This article belongs to the Special Issue Metal-Catalyzed Organic Transformations: Expanding Horizons in Synthetic Methodology)
Browse Figures
Versions Notes

Abstract

:
A novel synthesis strategy to access 2-alkoxyquinoline derivatives via a palladium-driven cascade reaction is disclosed. Unlike classic methods based on the alkylation of 2-quinolones with alkyl halides, the present method benefits from the de novo assembly of the quinoline core starting from 1,3-butadiynamides. Palladium-catalyzed reaction cascades with N-(2-iodophenyl)-N-tosyl-1,3-butadiynamides and primary alcohols as external nucleophiles proceed under mild reaction conditions and selectively deliver a variety of differently functionalized 4-alkenyl 2-alkoxyquinolines in a single batch transformation.

1. Introduction

The quinoline motif is found in the molecular structure of a large number of drugs, pharmaceuticals and natural products with relevant biological activities [1,2,3,4]. Therefore, quinolines serve as a privileged molecular platform for the development of new therapeutic agents. Within these, several differently functionalized 2-alkoxyquinolines have been reported (Figure 1):
For instance, bedaquiline I has been approved by the U.S. Food and Drug Administration for the treatment of drug-resistant tuberculosis [5]. 2-alkoxyquinoline II belongs to a set of novobiocin analogs where the 2-alkoxyquinoline replaces the original coumarin core. II displays anticancer activity by targeting the Hsp90 (heat-shock protein 90) C-terminal region (Figure 1) [6]. A series of 2-alkoxyquinolines bearing a lipophilic group at the 1- or 2-position was tested as new 5-HT3 receptor antagonists, and 2-alkoxyquinoline III revealed one of the highest affinities (Ki = 0.31 nM) [7]. 2-n-butyloxyquinoline dibucaine IV is a local anesthetic [8]. Furthermore, 2-alkoxyquinoline V functions as a nonsteroidal agonist of the farnesoid X receptor (FXR) [9], and 2-alkoxyquinoline VI is an antibacterial agent [10].
2-Alkoxyquinolines also play a crucial role as ligands in palladium-catalyzed C(sp3)–H bond functionalization, notably by enabling primary and secondary C(sp3)–H arylation [11,12], as well as γ-C(sp3)–H acetoxylation of triflyl-protected amines [13].
Typically, the synthesis of 2-alkoxyquinolines relies on the modification of suitable quinoline derivatives such as 2-chloroquinolines or 2-quinolones. SNAr reactions of 2-chloroquinolines with sodium alkoxides in alcohol deliver 2-alkoxyquinolines after several hours of heating under reflux [14]. Shorter reaction times of a few minutes were reported under microwave irradiation and in polar solvents such as HMPTA (hexamethylphosphortriamide) or NMP (N-methylpyrrolidone) [15]. Another classic synthesis method involves base-mediated O-alkylations of 2-quinolones by alkyl halides [6]. However, 2-quinolones are ambident nucleophiles due to their two tautomeric forms: 2-quinolone and 2-hydroxyquinoline. Here, the control of selectivity of O- versus N-alkylation is a non-negligible issue. Typically, O-alkylated products are obtained through the use of a stoichiometric amount of silver salts (Ag2CO3) [16,17]. The preferential interaction of the silver cation with the N atom ensures blocking of the N-site and liberates the O-nucleophilic site for O-alkylations. Recently, chemoselective Pd-catalyzed O-benzylations of 2-quinolones were achieved without the need of stoichiometric amounts of silver salts [18]. This process relies on the use of XantPhosPdCl2 as the pre-catalyst and the generation of a phosphine mono-oxide Pd(II) η1-benzyl complex as the key intermediate. However, the method is not applicable to alkyl halides other than benzyl halides. Whereas a variety of annulation reactions involving nonconventional bond-forming reactions have been developed for functionalized 2-quinolones [19,20], direct routes to 2-alkoxyquinolines based on the assembly of the quinoline core are rare. As an example, Brandsma described the synthesis of 2-O-silylated quinolines resulting from the reaction of phenyl isocyanate with lithiated allenes [21]. More recently, the DMAP-catalyzed synthesis of tert-butylquinolin-2-yl carbonates from 2-alkenylanilines and di-tert-butyl dicarbonate was reported [22].
Within our research on the chemistry of ynamides [23,24,25,26,27,28] and 1,3-butadiynamides [29,30,31], we recently disclosed a straightforward route to functionalized 2-amino-4-alkenylquinolines 4 from 1,3-butadiynamides 1 based on a palladium-catalyzed reaction cascade with primary or secondary amines 2 as external nucleophiles (Scheme 1a) [32].
The presence of TBAF (tetrabutylammonium fluoride) and KOH induces the cleavage of the tosyl group located at the ynamide nitrogen atom and ensures the involvement of both triple bonds in the annulation reaction cascade via the postulated σ,π-chelated Pd-species 3 as the key intermediate.
Extending the scope of this Pd-catalyzed cascade reaction is an attractive aim. When using readily available alcohols as nucleophiles, it would likely lead to a new approach to versatile 2-alkoxyquinolines via straightforward annulation reactions. We report here that primary alcohols 5 can indeed serve as suitable nucleophiles and reaction partners to convert readily accessible 1,3-butadiynamides 1 into functionalized 4-alkenyl 2-alkoxyquinolines 6 within a single batch and under mild conditions (Scheme 1b).

2. Results and Discussion

In our work related to the synthesis of 2-aminoquinolines 4, where primary or secondary amines served as nucleophiles, TBAF was added to the reaction to improve the solubility of KOH in THF through anion metathesis. Considering that the solubility of KOH is enhanced in methanol, the reaction of 1,3-butadiynamide 1a (R1 = n-Pr) was attempted without TBAF. Fortunately, diynamide 1a was now fully converted into the expected 4-alkenyl 2-methoxyquinoline 6a in the presence of Pd(PPh3)4 (10 mol%) and KOH (2.5 equiv) in methanol at 70 °C (Scheme 2). The 2-methoxyquinoline 6a was obtained in 75% yield with an (E)/(Z) ratio of 96:4 after column chromatography. Similarly, the 2-ethoxy analogue 6b was obtained in 79% isolated yield with an (E)/(Z) ratio of 97:3 when the reaction was carried out in EtOH as the solvent (Scheme 2). Notably, the yield of isolated 6b was not affected when the amount of EtOH was reduced from 165 to 10 equivalents and using THF as the solvent.
The option for utilizing more sophisticated alcohols was evaluated with 4-methyl-thiazol-5-yl-ethanol (5c). No reaction occurred between 1a and alcohol 5c (10 equiv) in THF after 1 h of heating at 70 °C and recovering the starting material 1a. This result might be due to the lack of solubility of KOH in the reaction medium. The addition of EtOH or MeOH to solubilize KOH could not be considered as these might compete as nucleophiles in this reaction. Therefore, the use of TBAF/KOH to induce an anion metathesis was again attempted. The reaction of 1a (0.11 mmol) with alcohol 5c (20 equiv) was performed in 1 mL of a commercially available 1M solution of TBAF in THF (9.5 equiv) in the presence of 10 mol% of Pd(PPh3)4 and 2.5 equivalents of KOH. Gratifyingly, under these modified reaction conditions, the expected 2-alkoxyquinoline 6c was obtained in 39% yield of the isolated material after 1 h at 70 °C (Scheme 2). The scope of this new 2-alkoxyquinoline synthesis was further studied using 10 mol% of Pd(PPh3)4, 2.5 equiv of KOH and 2.5 equiv of TBAF in THF as the standard reaction conditions. When glycol (5d) was used as the O-nucleophile, the product of mono-addition 6d was the sole product obtained (45% yield). The reaction was chemoselective with 1,3-butanediol (5e). Here, the primary alcohol reacted exclusively to give the corresponding 2-alkoxyquinoline 6e in 63% yield. It is worthy of note that access to quinolines 6d and 6e is not as straightforward using classic methods. Reactions with secondary or tertiary alcohols (i.e., cyclopentanol and tert-butanol, respectively) failed, probably due to steric reasons. On the other hand, alcohols tethered to an amino group, an olefin or an electron-rich or electron -poor aryl group were successfully engaged in this new and unprecedented 2-alkoxyquinoline synthesis and yielded a set of 2-alkoxy-4-alkenyl quinolines 6f-i in 40 to 75% yields of the isolated compounds (Scheme 2). In all cases, the (E) isomer was preferentially formed with an (E)/(Z) ratio higher than 95:5. The reaction of diynamide 1b (R1 = (CH2)2OBn) in EtOH as the solvent selectively led to the (E) isomer of the corresponding quinoline 6j in 65% yield of the isolated product. Interestingly, when the reaction was conducted in the presence of TBAF (2.5 equiv, condition B), the product was not 6j but 2-ethoxy-4-dienylquinoline 7a—the product resulting from the elimination of benzyl alcohol. Quinoline 7a was obtained in 30% yield via this extended reaction cascade, which terminates with the elimination of benzyl alcohol. Similarly, the reaction of 1b with 4-methyl-thiazol-5-yl-ethanol (5c) in the presence of TBAF yielded 4-dienyl-2-ethoxyquinoline 7b as the major product in 21% yield.
A deuterium labeling experiment was carried out with diynamide 1a in CD3OD using t-BuOK as the base instead of KOH to avoid any proton source (Scheme 3).
The resulting penta-deuterated quinoline 8a was isolated in 58% yield. The comparison of the 1H NMR spectrum of 8a with that of non-deuterated quinoline 6a provided evidence of the selective incorporation of deuterium into the C3 and C11 positions (Scheme 4). The 1H NMR signals at δ = 6.93 (s, H-3) and 6.97 (d, H-11) for the non-deuterated quinoline 6a almost disappeared in the 1H NMR spectrum of 8a. Moreover, the multiplicity of the signal assigned to the olefinic proton H-12 at δ = 6.41 was altered from a doublet of triplets with 3JH,H = 15.5 Hz and 3JH,H = 7.0 Hz to a triplet of triplets with 3JH,H = 7.0 Hz and 3JH,D(trans) = 2.0 Hz. The clear loss of the 1H signals at δ = 6.93 and 6.97, as well as the clear changes in the spin-system of the proton signal at δ = 6.41 in the 1H NMR spectra indicate an almost complete incorporation of deuterium at those positions.
The deuterium labelling experiment supports well the proposed mechanism outlined in Scheme 5. Presumably, the combination of alcohol 5/KOH or 5/TBAF/KOH cleaves the tosyl group located at the ynamide nitrogen atom (1 → 9A) and initiates the subsequent cascade reaction (Scheme 5). The resulting 1,3-butadiynamine 9A is in equilibrium with the alkynyl ketenimine 9B and the [4]-cumulenimine 9C with formal 1,3- and 1,5-H shifts, respectively. Selective 1,2-addition of alcohol 5 to either imine 9B or 9C followed by enamine-imine tautomerization—and isomerization of the propargyl to an allene moiety in the case of 9B—delivers the allene-derived intermediate 9D after oxidative addition of the palladium(0) catalyst. Whether the oxidative addition of palladium(0) already occurs with intermediates 9A–C and therefore facilitates the isomerization sequence or whether oxidative addition takes place after the 1,3-diynamine-to-allenyl-imine isomerization remains an open question. However, once the σ,π-chelated palladium intermediate 9D is formed, a subsequent intramolecular Heck-type reaction furnishes the annulated π-allyl palladium species 9E, which undergoes β-hydrogen elimination to produce 4-alkenyl quinolines 6 along with the palladium–hydride complex. Reduction of the latter by the base allows the regeneration of the Pd(0) active catalyst. Interestingly, in the case of 1,3-butadiynamide 1b (R1 = (CH2)2OBn), the reaction conditions indicated by B favor in situ elimination of benzyl alcohol and yield 2-alkoxy-4-(1,3-dienyl)quinolines 7 as the major products. Here, the formation of the conjugated 1,3-butadiene moiety is most likely the underlying driving force.

3. Materials and Methods

Chromatographic purification steps were performed using Acros Organics silica gel Si 60 (40–60 μm) or Merck aluminum oxide 90 active neutral (60–200 μm, activity stage III). Thin-layer chromatography (TLC) was developed on Merck silica gel 60 plates (0.20 mm) or on aluminum oxide 60 neutral plates (0.20 mm) with UV detection (Merck, Kenilworth, NJ, USA). Nuclear magnetic resonance (NMR) spectra were recorded on a BRUKER AVANCE III 500 (500 MHz) or a BRUKER NEO 600 (600 MHz) spectrometer (Bruker, Billerica, Kenilworth, MA, USA). 1H and 13C NMR chemical shifts (δ) are given in ppm (parts per million) using the TMS signal (0 ppm) and the residual peak of chloroform-D (77.16 ppm), respectively, as the internal reference (see Supplementary Materials). Coupling constants are reported in Hertz (Hz). The following abbreviations are used: s = singlet, d = doublet, t = triplet, q = quartet, qt = quintuplet, sext = sextuplet, m = multiplet, br = broad). The (E)/(Z) isomer ratio was determined for each quinoline from the 1H NMR spectrum via integration of the dt signals of the olefin proton of both isomers. High-resolution mass spectrometry (HRMS) analysis was performed in electron spray ionization (ESI) mode on an Acquity UPLC H-ClassXevo G2-XS QTof (WATERS) spectrometer (Waters, Milford, MA, USA). Melting points (Mp) were measured with an electrothermal apparatus and are not corrected. The procedure for the synthesis of 1,3-butadiynamides 1a,b and their characterization data were reported [32,33].

3.1. General Procedure for the Synthesis of 2-Alkoxyquinolines 6a–b, f, j (Condition A)

1,3-butadiynamide 1 (0.11 mmol), KOH (15 mg, 0.26 mmol, 2.5 equiv), tetrakis(triphenylphosphine)palladium(0) (Pd(PPh3)4) (12 mg, 10 mol%) and alcohol 5 (1 mL) were introduced in a dry Schlenk tube under an argon atmosphere. The Schlenk tube was immediately placed in an oil bath preheated to 70 °C. After 1 h, CH2Cl2 and brine were added to the reaction mixture. The aqueous phase was extracted with CH2Cl2, and the combined organic layers were dried (MgSO4), filtered and evaporated under reduced pressure. The product was purified via silica gel or alumina column chromatography.
2-Methoxy-4-(pent-1-en-1-yl)quinoline (6a). Prepared from N-(2-iodophenyl)-4-methyl-N-(octa-1,3-diyn-1-yl)benzenesulfonamide (1a) (50 mg, 0.105 mmol) and MeOH (5a) (1 mL). The product was purified via column chromatography (Al2O3, n-pentane/Et2O 20:1 (v/v)) to yield 6a as an oil (18 mg, 0.08 mmol, yield: 75%, E/Z = 96:4). Rf = 0.53 (n-pentane/Et2O = 20:1 (v/v)). 1H NMR (500 MHz, CDCl3) δ 7.97 (d, 3J = 7.9 Hz, 1 H), 7.86 (d, 3J = 8.3 Hz, 1 H), 7.61 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.2 Hz, 1 H), 7.38 (ddd, 3J = 8.1 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 6.97 (d, 3J = 15.7 Hz, 1 H), 6.93 (s, 1 H), 6.41 (dt, 3J = 15.5 Hz, 3J = 7.0 Hz, 1 H), 4.07 (s, 3 H), 2.31 (m, 2 H), 1.57 (sext, 3J = 7.4 Hz, 2 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.02 (dt, 3J = 11.6 Hz, 3J = 7.5 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 162.7 (C), 147.1 (C), 146.7 (C), 138.0 (CH), 129.4 (CH), 127.8 (CH), 124.9 (CH), 123.89 (CH), 123.85 (C), 123.8 (CH), 108.7 (CH), 53.4 (CH3), 35.6 (CH2), 22.4 (CH2) and 13.9 (CH3). HRMS (ESI+): Calc’d for C15H18NO [M + H]+: 228.1388; found: 228.1395.
2-Ethoxy-4-(pent-1-en-1-yl)quinoline (6b). Prepared from 1a (50 mg, 0.105 mmol) in EtOH (5b) (1 mL). The product was purified via column chromatography (Al2O3, n-pentane/Et2O 20:1 (v/v)) to yield 6b as an oil (20 mg, 0.083 mmol, yield: 79%, E/Z = 97:3). Rf = 0.62 (n-pentane/Et2O = 20:1 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.96 (dd, 3J = 8.3 Hz, 4J = 1.1 Hz, 1 H), 7.83 (d, 3J = 8.3 Hz, 1 H), 7.59 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.4 Hz, 1 H), 7.36 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 6.97 (d, 3J = 15.6 Hz, 1 H), 6.93 (s, 1 H), 6.41 (dt, 3J = 15.5 Hz, 3J = 7.0 Hz, 1 H), 4.53 (q, 3J = 7.1 Hz, 2 H), 2.30 (m, 2 H), 1.57 (sext, 3J = 7.4 Hz, 2 H), 1.45 (t, 3J = 7.1 Hz, 3 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.01 (dt, 3J = 11.6 Hz, 3J = 7.5 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 162.4 (C), 147.2 (C), 146.6 (C), 137.8 (CH), 129.4 (CH), 127.8 (CH), 124.9 (CH), 123.78 (C), 123.76 (CH), 123.7 (CH), 108.9 (CH), 61.7 (CH2), 35.6 (CH2), 22.4 (CH2), 14.8 (CH3) and 13.9 (CH3). HRMS (ESI+): Calc’d for C16H20NO [M + H]+: 242.1545; found: 242.1547.
N,N-Dimethyl-2-((4-(pent-1-en-1-yl)quinolin-2-yl)oxy)ethanamine (6f). Prepared from 1a (50 mg, 0.105 mmol) and 3-(dimethylamino)propan-1-ol (5f) (105 μL, 1.1 mmol, 10 equiv) in dry THF (1 mL). The reaction was complete after 30 min at 70 °C. The product was purified via column chromatography (Al2O3, n-pentane/EtOAc/Et3N 90:10:1 (v/v/v)) to yield 6f (19 mg, 0.067 mmol, yield: 64%, E/Z = 97:3) as an oil. Rf = 0.37 (n-pentane/EtOAc/Et3N 90:10:1 (v/v/v)). 1H NMR (500 MHz, CDCl3) δ 7.97 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H), 7.82 (d, 3J = 8.3 Hz, 1 H), 7.59 (ddd, 3J = 8.4 Hz, 3J = 7.0 Hz, 4J = 1.4 Hz, 1 H), 7.37 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.2 Hz, 1 H), 7.01 (s, 1 H), 6.97 (d, 3J = 15.6 Hz, 1 H), 6.40 (dt, 3J = 15.6 Hz, 3J = 7.0 Hz, 1 H), 4.59 (t, 3J = 5.6 Hz, 2 H), 2.78 (t, 3J = 5.6 Hz, 2 H), 2.37 (s, 6 H), 2.30 (m, 2 H), 1.56 (sext, 3J = 7.3 Hz, 2 H) and 1.00 (t, 3J = 7.3 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.01 (dt, 3J = 11.6 Hz, 3J = 7.4 Hz, 1 H). 13C NMR (125 MHz, CDCl3) δ 162.3 (C), 147.1 (C), 146.5 (C), 137.9 (CH), 129.3 (CH), 127.8 (CH), 124.8 (CH), 123.9 (C), 123.8 (CH), 123.7 (CH), 109.1 (CH), 63.2 (CH2), 58.4 (CH2), 45.9 (CH3), 35.5 (CH2), 22.4 (CH2) and 13.8 (CH3). HRMS (ESI+): Calc’d for C18H25N2O [M + H]+: 285.1967; found: 285.1968.
(E)-4-(4-(Benzyloxy)but-1-en-1-yl)-2-ethoxyquinoline (6j). Prepared from N-(7-(benzyloxy)hepta-1,3-diyn-1-yl)-N-(2-iodophenyl)-4-methylbenzenesulfonamide (1b) (50 mg, 0.088 mmol) in EtOH (1 mL). The reaction was complete after 30 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/Et2O 20:1 (v/v)) to yield (E)-6j as an oil (19 mg, 0.057 mmol, yield: 65%). Rf = 0.25 (n-pentane/Et2O 20:1 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.94 (d, 3J = 8.2 Hz, 1 H), 7.82 (d, 3J = 8.3 Hz, 1 H), 7.60 (dd, 3J = 8.0 Hz, 3J = 7.1 Hz, 1 H), 7.36-7.28 (m, 6 H), 7.05 (d, 3J = 15.7 Hz, 1 H), 6.93 (s, 1 H), 6.43 (dt, 3J = 15.6 Hz, 3J = 7.0 Hz, 1 H), 4.57 (s, 2 H), 4.52 (q, 3J = 7.1 Hz, 2 H), 3.66 (t, 3J = 6.5 Hz, 2 H), 2.65 (m, 2 H) and 1.45 (t, 3J = 7.1 Hz, 3 H). 13C NMR (150 MHz, CDCl3) δ 162.4 (C), 147.2 (C), 146.2 (C), 138.4 (C), 134.0 (CH), 129.4 (CH), 128.6 (CH), 127.9 (CH), 127.82 (CH), 127.80 (CH), 126.6 (CH), 123.8 (CH), 123.72 (CH), 123.69 (C), 109.1 (CH), 73.2 (CH2), 69.5 (CH2), 61.6 (CH2), 34.0 (CH2) and 14.8 (CH3). HRMS (ESI+): Calc’d for C22H24NO2 [M + H]+: 334.1807; found: 334.1808.

3.2. General Procedure for the Synthesis of 2-Alkoxyquinolines 6c–e, g-i and 7a–b (Condition B)

1,3-butadiynamide 1 (0.11 mmol), KOH (15 mg, 0.26 mmol, 2.5 equiv), Pd(PPh3)4 (12 mg, 10 mol%), alcohol 5 (10–20 equiv), tetra-n-butylammonium fluoride (TBAF) 1M solution in THF (0.3 mL, 0.3 mmol, 2.5 equiv) and dry THF (1 mL) were introduced in a Schlenk tube under an argon atmosphere. The Schlenk tube was immediately placed in an oil bath preheated to 70 °C. Upon completion of the reaction (0.5 to 1 h), CH2Cl2 and brine were added to the reaction mixture. The aqueous phase was extracted with CH2Cl2 and the combined organic layers were dried (MgSO4), filtered and evaporated under reduced pressure. The product was purified via silica gel or alumina column chromatography.
4-Methyl-5-(2-((4-(pent-1-en-1-yl)quinolin-2-yl)oxy)ethyl)thiazole (6c). Prepared from 1a (50 mg, 0.105 mmol) and 2-(4-methylthiazol-5-yl)ethanol (5c) (0.25 mL, 2.1 mmol, 20 equiv) in 1 mL of 1M tetra-n-butylammonium fluoride (TBAF) solution in THF (1 mmol, 9.5 equiv). The reaction was complete after 1 h at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/EtOAc/Et3N 90:10:1 (v/v/v)) to yield 6c as an oil (14 mg, 0.041 mmol, yield: 39%, E/Z = 95:5). Rf = 0.20 (n-pentane/EtOAc/Et3N 90:10:1 (v/v/v)). 1H NMR (600 MHz, CDCl3) δ 8.59 (s, 1 H), 7.98 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H), 7.82 (d, 3J = 8.3 Hz, 1 H), 7.61 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.4 Hz, 1 H), 7.38 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 6.98 (d, 3J = 15.8 Hz, 1 H), 6.93 (s, 1 H), 6.42 (dt, 3J = 15.6 Hz, 3J = 7.0 Hz, 1 H), 4.64 (t, 3J = 6.7 Hz, 2 H), 3.30 (t, 3J = 6.7 Hz, 2 H), 2.48 (s, 3 H), 2.32 (m, 2 H), 1.58 (sext, 3J = 7.3 Hz, 2 H) and 1.01 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.03 (dt, 3J = 11.6 Hz, 3J = 7.5 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 161.8 (C), 149.9 (C), 149.8 (CH), 147.0 (C), 146.9 (C), 138.1 (CH), 129.5 (CH), 127.8 (CH), 127.7 (C), 124.8 (CH), 124.0 (CH), 123.9 (C), 123.8 (CH), 108.6 (CH), 65.4 (CH2), 35.6 (CH2), 26.3 (CH2), 22.4 (CH2), 15.2 (CH3) and 13.9 (CH3). HRMS (ESI+): Calc’d for C20H23N2OS [M + H]+: 339.1531; found: 339.1530.
2-((4-(pent-1-en-1-yl)quinolin-2-yl)oxy)ethanol (6d). Prepared from 1a (50 mg, 0.105 mmol) and ethylene glycol (5d) (120 μL, 2.1 mmol, 20 equiv). The reaction was complete after 1 h at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/EtOAc/Et3N 80:20:1 (v/v/v) to 60:40:1 (v/v/v)) to yield 6d as an oil (12 mg, 0.047 mmol, yield: 45%, E/Z = 98:2). Rf = 0.17 (pentane/EtOAc/Et3N 80:20:1 (v/v/v)). 1H NMR (600 MHz, CDCl3) δ 7.98 (d, 3J = 8.2 Hz, 1 H), 7.80 (d, 3J = 8.2 Hz, 1 H), 7.62 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 7.40 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.1 Hz, 1 H), 6.99 (s, 1 H), 6.98 (d, 3J = 15.4 Hz, 1 H), 6.43 (dt, 3J = 15.4 Hz, 3J = 7.0 Hz, 1 H), 4.74 (br s, 1 H), 4.64 (m, 2 H), 4.00 (m, 2 H), 2.32 (m, 2 H), 1.57 (sext, 3J = 7.4 Hz, 2 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.05 (dt, 3J = 11.6 Hz, 3J = 7.4 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 162.6 (C), 147.5 (C), 146.3 (C), 138.5 (CH), 129.8 (CH), 127.3 (CH), 124.7 (CH), 124.3 (CH), 123.9 (C), 123.8 (CH), 108.8 (CH), 69.6 (CH2), 63.1 (CH2), 35.6 (CH2), 22.3 (CH2) and 13.9 (CH3). HRMS (ESI+): Calc’d for C16H20NO2 [M + H]+: 258.1494; found: 258.1497.
4-((4-(pent-1-en-1-yl)quinolin-2-yl)oxy)butan-2-ol (6e). Prepared from 1a (50 mg, 0.105 mmol) and 1,3-butanediol (5e) (190 μL, 2.1 mmol, 20 equiv). The reaction was complete after 40 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/AcOEt/Et3N 90:10:1 (v/v/v) to 80:20:1 (v/v/v)) to yield 6e as an oil (19 mg, 0.067 mmol, yield: 63%, E/Z = 98:2). Rf = 0.65 (n-pentane/AcOEt 6:4 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.98 (dd, 3J = 8.3 Hz, 4J = 1.1 Hz, 1 H), 7.80 (d, 3J = 8.2 Hz, 1 H), 7.61 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.4 Hz, 1 H), 7.39 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 6.97 (d, 3J = 15.6 Hz, 1 H), 6.93 (s, 1 H), 6.43 (dt, 3J = 15.5 Hz, 3J = 7.0 Hz, 1 H), 5.09 (m, 1 H), 4.79 (br s, 1 H), 4.34 (m, 1 H), 3.83 (m, 1 H), 2.32 (m, 2 H), 2.01 (m, 1 H), 1.76 (m, 1 H), 1.57 (sext, 3J = 7.4 Hz, 2 H), 1.23 (d, 3J = 6.2 Hz, 3 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.03 (dt, 3J = 11.7 Hz, 3J = 7.4 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 162.8 (C), 147.4 (C), 146.3 (C), 138.5 (CH), 129.9 (CH), 127.2 (CH), 124.7 (CH), 124.2 (CH), 123.79 (C), 123.78 (CH), 108.8 (CH), 63.7 (CH), 63.0 (CH2), 39.9 (CH2), 35.6 (CH2), 22.9 (CH3), 22.3 (CH2) and 13.9 (CH3). HRMS (ESI+): Calc’d for C18H24NO2 [M + H]+: 286.1807; found: 286.1806.
2-((3-Methylbut-3-en-1-yl)oxy)-4-(pent-1-en-1-yl)quinoline (6g). Prepared from 1a (50 mg, 0.105 mmol) and 2-methylprop-2-en-1-ol (5g) (215 μL, 2.1 mmol, 20 equiv). The reaction was complete after 45 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/Et2O 20:1 (v/v)) to yield 6g as an oil (22 mg, 0.078 mmol, yield: 75%, E/Z = 97:3). Rf = 0.65 (n-pentane/Et2O 20:1 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.97 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H), 7.84 (dd, 3J = 8.3 Hz, 4J = 0.8 Hz, 1 H), 7.60 (ddd, 3J = 8.3 Hz, 3J = 6.8 Hz, 4J = 1.4 Hz, 1 H), 7.37 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 6.97 (d, 3J = 15.8 Hz, 1 H), 6.94 (s, 1 H), 6.42 (dt, 3J = 15.5 Hz, 3J = 7.0 Hz, 1 H), 4.85 (s, 2 H), 4.59 (t, 3J = 6.8 Hz, 2 H), 2.55 (t, 3J = 6.8 Hz, 2 H), 2.30 (m, 2 H), 1.85 (s, 3 H), 1.56 (sext, 3J = 7.4 Hz, 2 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.01 (dt, 3J = 11.6 Hz, 3J = 7.4 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 162.4 (C), 147.2 (C), 146.6 (C), 142.7 (C), 137.8 (CH), 129.3 (CH), 127.8 (CH), 124.9 (CH), 123.83 (C), 123.78 (CH), 123.7 (CH), 112.0 (CH2), 108.9 (CH), 64.1 (CH2), 37.3 (CH2), 35.6 (CH2), 22.9 (CH3), 22.4 (CH2) and 13.9 (CH3). HRMS (ESI+): Calc’d for C19H24NO [M + H]+: 282.1858; found: 282.1863.
(E)-2-(Benzo[d][1,3]dioxol-5-ylmethoxy)-4-(pent-1-en-1-yl)quinoline (6h). Prepared from 1a (50 mg, 0.105 mmol) and benzo[d][1,3]dioxol-5-ylmethanol (5h) (320 mg, 2.1 mmol, 20 equiv). The reaction was complete after 30 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/Et2O 20:1 (v/v)) to yield (E)-6h as an oil (21 mg, 0.06 mmol, yield: 58%). Rf = 0.48 (n-pentane/Et2O 20:1 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.98 (dd, 3J = 8.3 Hz, 4J = 1.1 Hz, 1 H), 7.86 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H), 7.61 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.4 Hz, 1 H), 7.39 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.3 Hz, 1 H), 7.04 (d, 4J = 1.6 Hz, 1 H), 7.00 (dd, 3J = 7.9 Hz, 4J = 1.6 Hz, 1 H), 6.98 (s, 1 H), 6.97 (d, 3J = 15.6 Hz, 1 H), 6.82 (d, 3J = 7.9 Hz, 1 H), 6.40 (dt, 3J = 15.6 Hz, 3J = 7.0 Hz, 1 H), 5.96 (s, 2 H), 5.44 (s, 2 H), 2.30 (m, 2 H), 1.56 (sext, 3J = 7.4 Hz, 2 H) and 0.99 (t, 3J = 7.4 Hz, 3 H). 13C NMR (150 MHz, CDCl3) δ 162.0 (C), 147.8 (C), 147.4 (C), 147.1 (C), 146.8 (C), 138.0 (CH), 131.3 (C), 129.4 (CH), 127.9 (CH), 124.8 (CH), 124.0 (CH), 123.9 (C), 123.7 (CH), 122.3 (CH), 109.3 (CH), 108.9 (CH), 108.3 (CH), 101.2 (CH2), 67.6 (CH2), 35.6 (CH2), 22.4 (CH2) and 13.9 (CH3). HRMS (ESI+): Calc’d for C22H22NO3 [M + H]+: 348.1600; found: 348.1601.
2-(4-Fluorophenyl)ethoxy)-4-(pent-1-en-1-yl)quinoline (6i). Prepared from 1a (50 mg, 0.105 mmol) and 2-(4-fluorophenyl)ethanol (5i) (130 μL, 1.05 mmol, 10 equiv). The reaction was complete after 40 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/Et2O 98:2 (v/v)) to yield 6i as a white solid (14 mg, 0.04 mmol, yield: 40%, E/Z = 98:2). Mp 48–49 °C. Rf = 0.53 (n-pentane/EtOAc 95:5 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.96 (d, 3J = 8.2 Hz, 1 H), 7.81 (d, 3J = 8.4 Hz, 1 H), 7.59 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.3 Hz, 1 H), 7.37 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.1 Hz, 1 H), 7.29-7.27 (m, 2 H), 7.00 (m, 2 H), 6.96 (d, 3J = 15.6 Hz, 1 H), 6.91 (s, 1 H), 6.40 (dt, 3J = 15.6 Hz, 3J = 7.0 Hz, 1 H), 4.66 (t, 3J = 7.0 Hz, 2 H), 3.11 (t, 3J = 7.0 Hz, 2 H), 2.30 (m, 2 H), 1.56 (sext, 3J = 7.4 Hz, 2 H) and 1.00 (t, 3J = 7.4 Hz, 3 H). Identified 1H NMR signals corresponding to the minor isomer: 6.02 (dt, 3J = 11.7 Hz, 3J = 7.4 Hz, 1 H). 13C NMR (150 MHz, CDCl3) δ 161.7 (d, 1JC-F = 242 Hz, C), 162.2 (C), 147.2 (C), 146.7 (C), 137.9 (CH), 134.5 (d, 4JC-F = 3 Hz, C), 130.6 (d, 3JC-F = 8 Hz, CH), 129.4 (CH), 127.8 (CH), 124.8 (CH), 123.9 (CH), 123.8 (C), 123.7 (CH), 115.3 (d, 2JC-F = 21 Hz, CH), 108.8 (CH), 66.3 (CH2), 35.6 (CH2), 34.8 (CH2), 22.4 (CH2) and 13.9 (CH3). 19F{H} NMR (470 MHz, CDCl3) δ -117.0. HRMS (ESI+): Calc’d for C22H23NOF [M + H]+: 336.1764; found: 336.1761.
(E)-2-Ethoxy-4-(buta-1,3-dien-1-yl)quinoline (7a). Prepared from N-(7-(benzyloxy)hepta-1,3-diyn-1-yl)-N-(2-iodophenyl)-4-methylbenzenesulfonamide (1b) (57 mg, 0.1 mmol) and EtOH (5b) (120 μL, 2.0 mmol, 20 equiv). The reaction was complete after 50 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/EtOAc 98:2 (v/v)) to yield (E)-7a as a white solid (7 mg, 0.03 mmol, yield: 30%). Mp 64–65 °C. Rf = 0.4 (n-pentane/EtOAc 98:2 (v/v)). 1H NMR (600 MHz, CDCl3) δ 7.97 (dd, 3J = 8.3 Hz, 4J = 1.1 Hz, 1 H), 7.83 (dd, 3J = 8.3 Hz, 4J = 0.7 Hz, 1 H), 7.61 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.4 Hz, 1 H), 7.38 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.3 Hz, 1 H), 7.17 (br d, 3J = 15.4 Hz, 1 H), 7.01 (s, 1 H), 6.95 (ddt, 3J = 15.4 Hz, 3J = 10.5 Hz, 4J = 0.7 Hz, 1 H), 6.64 (dddd, 3J = 16.9 Hz, 3J = 10.6 Hz, 3J = 10.0 Hz, 4J = 0.7 Hz, 1 H), 5.47 (dddd, 3J = 16.9 Hz, 2J = 1.4 Hz, 4J = 0.7 Hz, 5J = 0.7 Hz, 1 H), 5.34 (dddd, 3J = 10.0 Hz, 2J = 1.4 Hz, 4J = 0.7 Hz, 5J = 0.7 Hz, 1 H), 4.53 (q, 3J = 7.1 Hz, 2 H) and 1.45 (t, 3J = 7.1 Hz, 3 H). 13C NMR (150 MHz, CDCl3) δ 162.3 (C), 147.4 (C), 145.3 (C), 136.8 (CH), 135.5 (CH), 129.5 (CH), 128.0 (CH), 127.0 (CH), 123.9 (CH), 123.6 (C), 123.4 (CH), 120.6 (CH2), 108.7 (CH), 61.7 (CH2) and 14.8 (CH3). HRMS (ESI+): Calc’d for C15H16NO [M + H]+: 226.1232; found: 226.1233.
(E)-5-(2-((4-(buta-1,3-dien-1-yl)quinolin-2-yl)oxy)ethyl)-4-methylthiazole (7b). Prepared from 1b (50 mg, 0.088 mmol) and 2-(4-methylthiazol-5-yl)ethanol (5c) (210 μL, 1.8 mmol, 20 equiv). The reaction was complete after 50 min at 70 °C. The product was purified via column chromatography (SiO2, n-pentane/EtOAc/Et3N 90:10:1 (v/v/v)) to yield (E)-7b (6 mg, 0.019 mmol, yield: 21%) as an oil. Rf = 0.19 (n-pentane/EtOAc 90:10 (v/v)). 1H NMR (600 MHz, CDCl3) δ 8.60 (s, 1 H), 7.99 (dd, 3J = 8.3 Hz, 4J = 0.9 Hz, 1 H), 7.83 (dd, 3J = 8.3 Hz, 4J = 0.7 Hz, 1 H), 7.62 (ddd, 3J = 8.3 Hz, 3J = 6.9 Hz, 4J = 1.3 Hz, 1 H), 7.41 (ddd, 3J = 8.2 Hz, 3J = 7.0 Hz, 4J = 1.2 Hz, 1 H), 7.18 (d, 3J = 15.5 Hz, 1 H), 7.02 (s, 1 H), 6.96 (dd, 3J = 15.4 Hz, 3J = 10.6 Hz, 1 H), 6.65 (ddd, 3J = 16.9 Hz, 3J = 10.4 Hz, 3J = 10.1 Hz, 1 H), 5.50 (d, 3J = 16.9 Hz, 1 H), 5.36 (d, 3J = 10.0 Hz, 1 H), 4.65 (t, 3J = 6.7 Hz, 2 H), 3.31 (t, 3J = 6.7 Hz, 2 H) and 2.49 (s, 3 H). 13C NMR (150 MHz, CDCl3) δ 161.8 (C), 149.94 (C), 149.88 (CH), 147.2 (C), 145.6 (C), 136.8 (CH), 135.7 (CH), 129.7 (CH), 128.0 (CH), 127.7 (C), 126.8 (CH), 124.2 (CH), 123.7 (C), 123.5 (CH), 120.8 (CH2), 108.4 (CH), 65.5 (CH2), 26.3 (CH2) and 15.2 (CH3). HRMS (ESI+): Calc’d for C19H19N2OS [M + H]+: 323.1218; found: 323.1218.

3.3. Deuterium Labeling Experiments

1,3-butadiynamide 1a (48 mg, 0.10 mmol), tetrakis(triphenylphosphine)palladium(0) (12 mg, 0.01 mmol, 10 mol%) and t-BuOK (28 mg, 0.25 mmol, 2.5 equiv) were introduced in a dry Schlenk tube under argon atmosphere. Then CD3OD (0.75 mL) was added. The Schlenk tube was sealed and immediately placed in an oil bath preheated to 70 °C. After 30 min, the reaction mixture was diluted with EtOAc and washed with brine. After drying (MgSO4), the organic layer was filtered and evaporated under reduced pressure. The product was purified via column chromatography (SiO2 pretreated with n-pentane/Et2O/Et3N 94:2:2 (v/v/v), n-pentane/Et2O 98:2 to 95:5 (v/v)) to yield 8a as an oil (13.5 mg, 0.058 mmol, yield: 58%). Rf = 0.72 (n-pentane/Et2O 10:1 (v/v)).
D5-2-Methoxy-4-(pent-1-en-1-yl)quinoline (8a). 1H NMR (500 MHz, CDCl3) δ 7.98 (dd, 3J = 8.3 Hz, 4J = 1.0 Hz, 1 H, H5), 7.90 (m, 1 H, H8), 7.62 (ddd, 3J = 8.3 Hz, 3J = 7.0 Hz, 4J = 1.2 Hz, 1 H, H7), 7.39 (ddd, 3J = 8.1 Hz, 3J = 7.0 Hz, 4J = 1.0 Hz, 1 H, H6), 6.42 (tt, 3J = 7.0 Hz, 3J = 2 Hz, 1 H, H12), 2.32 (qapp, 3J = 7.2 Hz, 2 H, H13), 1.57 (sext, 3J = 7.4 Hz, 2 H, H14) and 1.00 (t, 3J = 7.4 Hz, 3 H, H15). HRMS (ESI+): Calc’d for C15H13D5NO [M + H]+: 233.1702; found: 233.1704.

4. Conclusions

In conclusion, we have developed a straightforward Pd-catalyzed route to 2-alkoxy 4-alkenylquinolines starting from readily accessible 1,3-butadiynamides. Classic synthetic methods for 2-alkoxyquinolines rely on modifications of the quinoline core and usually yield quinolines with simple alkoxy moieties at the 2-position. By contrast, the presented synthesis strategy is based on the de novo assembly of the 2-alkoxyquinoline core from acyclic precursors—1,3-butadiynamides and primary alcohols as external nucleophiles—to access a highly varied set of 2-alkoxyquinoline derivatives that are otherwise difficult to obtain. The removal of the ynamide tosyl group occurs under defined reaction conditions, which include the use of TBAF/KOH in THF. This initiates the in situ generation of highly reactive and sensitive ketenimine and/or [4]cumulenimine species, which trigger a palladium-catalyzed cascade reaction involving bond formation and cleavage as well as several tautomeric isomerization steps, ultimately leading to highly functionalized 2-alkoxyquinolines.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules29153505/s1, Experimental procedures and characterization data of 1,3-butadiynamides 1a,b [32,33] and NMR spectra for all new compounds.

Author Contributions

Conceptualization, methodology, supervision, project administration and funding acquisition, C.A. and B.W.; formal analysis, investigation, data validation and curation, I.L. and A.M.; writing—original draft preparation, writing—review and editing, C.A. and B.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the French Agence Nationale de la Recherche (ANR-22-CE07-0010), CNRS, Normandie Univ, Conseil Régional de Normandie, and the European FEDER funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available on request from the authors.

Acknowledgments

We thank Karine Jarsalé and Rémi Legay for technical assistance and discussions in mass spectrometry and NMR analyses.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Saxena, A.; Majee, S.; Ray, D.; Saha, B. Inhibition of Cancer Cells by Quinoline-Based Compounds: A Review with Mechanistic Insights. Bioorg. Med. Chem. 2024, 103, 117681. [Google Scholar] [CrossRef]
  2. Zhao, Y.-Q.; Li, X.; Guo, H.-Y.; Shen, Q.-K.; Quan, Z.-S.; Luan, T. Application of Quinoline Ring in Structural Modification of Natural Products. Molecules 2023, 28, 6478. [Google Scholar] [CrossRef]
  3. Michael, J.P. Quinoline, Quinazoline and Acridone Alkaloids. Nat. Prod. Rep. 2008, 25, 166–187. [Google Scholar] [CrossRef]
  4. Gorka, A.P.; de Dios, A.; Roepe, P.D. Quinoline Drug–Heme Interactions and Implications for Antimalarial Cytostatic versus Cytocidal Activities. J. Med. Chem. 2013, 56, 5231–5246. [Google Scholar] [CrossRef]
  5. Negi, A.; Perveen, S.; Gupta, R.; Singh, P.P.; Sharma, R. Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid. J. Med. Chem. 2024, 67, 2264–2286. [Google Scholar] [CrossRef]
  6. Kusuma, B.R.; Khandelwal, A.; Gu, W.; Brown, D.; Liu, W.; Vielhauer, G.; Holzbeierlein, J.; Blagg, B.S.J. Synthesis and Biological Evaluation of Coumarin Replacements of Novobiocin as Hsp90 Inhibitors. Bioorg. Med. Chem. 2014, 22, 1441–1449. [Google Scholar] [CrossRef]
  7. Hayashi, H.; Miwa, Y.; Miki, I.; Ichikawa, S.; Yoda, N.; Ishii, A.; Kono, M.; Suzuki, F. 5-HT3 Receptors Antagonists. 1. New Quinoline Derivatives. J. Med. Chem. 1992, 35, 4893–4902. [Google Scholar] [CrossRef]
  8. Kalajian, T.A.; Cannella, J.A.; Vasudevan, A.; Mizelle, J.; Rendon, L.F.; Nozari, A.; Ortega, R. An Overview of Local Anesthetics in Over-the counter Products. Pain Pract. 2024, 24, 364–373. [Google Scholar] [CrossRef]
  9. Abel, U.; Schlüter, T.; Schulz, A.; Hambruch, E.; Steeneck, C.; Hornberger, M.; Hoffmann, T.; Perovic-Ottstadt, S.; Kinzel, O.; Burnet, M.; et al. Synthesis and Pharmacological Validation of a Novel Series of Non-steroidal FXR Agonists. Bioorg. Med. Chem. Lett. 2010, 20, 4911–4917. [Google Scholar] [CrossRef]
  10. Kidwai, M.; Sapra, P.; Misra, P.; Saxena, R.K.; Singh, M. Microwave Assisted Solid Support Synthesis of Novel 1,2,4-Triazolo [3,4-b]-1,3,4-thiadiazepines as Potent Antimicrobial Agents. Bioorg. Med. Chem. 2001, 9, 217–220. [Google Scholar] [CrossRef]
  11. Wasa, M.; Chan, K.S.L.; Zhang, X.-G.; He, J.; Miura, M.; Yu, J.-Q. Ligand-Enabled Methylene C(sp3)-H Bond Activation with a Pd(II) Catalyst. J. Am. Chem. Soc. 2012, 134, 18570–18572. [Google Scholar] [CrossRef]
  12. He, J.; Li, S.; Deng, Y.; Fu, H.; Laforteza, B.N.; Spangler, J.E.; Homs, A.; Yu, J.-Q. Ligand-Controlled C(sp3)-H Arylation and Olefination in Synthesis of Unnatural Chiral α-Amino Acids. Science 2014, 343, 1216–1220. [Google Scholar] [CrossRef]
  13. Jia, W.-L.; Fernandez-Ibanez, M.A. Ligand-Enabled γ-C(sp3)-H Acetoxylation of Triflyl-Protected Amines. Eur. J. Org. Chem. 2018, 2018, 6088–6091. [Google Scholar] [CrossRef]
  14. Broch, S.; Aboab, B.; Anizon, F.; Moreau, P. Synthesis and In Vitro Antiproliferative Activities of Quinoline Derivatives. Eur. J. Med. Chem. 2010, 45, 1657–1662. [Google Scholar] [CrossRef]
  15. Cherng, Y.-J. Efficient Nucleophilic Substitution Reactions of Quinolyl and Isoquinolyl Halides with Nucleophiles under Focused Microwave Irradiation. Tetrahedron 2002, 58, 1125–1129. [Google Scholar] [CrossRef]
  16. Morel, A.F.; Larghi, E.L.; Selvero, M.M. Mild, Efficient and Selective Silver Carbonate Mediated O-Alkylation of 4-Hydroxy-2-quinolones: Synthesis of 2,4-Dialkoxyquinolines. Synlett 2005, 2005, 2755–2758. [Google Scholar] [CrossRef]
  17. Lu, Z.; Li, Y.; Ru, Y.; Yang, S.; Hao, C.; Zuo, M.; Jiao, R.; Wu, W.; Zhou, Y.; Yao, H.; et al. Coordination Effect Enabled Palladium-Catalyzed Regioselective O-Alkylation of 2-Pyridones. Chem. Commun. 2022, 58, 1215–1218. [Google Scholar] [CrossRef]
  18. Cadena, M.; Villatoro, R.S.; Gupta, J.S.; Phillips, C.; Allen, J.B.; Arman, H.D.; Wherritt, D.J.; Clanton, N.A.; Ruchelman, A.L.; Simmons, E.M.; et al. Pd-Catalyzed Chemoselective O-Benzylation of Ambident 2-Quinolone Nucleophiles. ACS Catal. 2022, 12, 10199–10206. [Google Scholar] [CrossRef]
  19. Silva, V.L.M.; Silva, A.M.S. Palladium-Catalyzed Synthesis and Transformation of Quinolones. Molecules 2019, 24, 228. [Google Scholar] [CrossRef]
  20. Hong, W.P.; Shin, I.; Lim, H.N. Recent Advances in One-Pot Modular Synthesis of 2-Quinolones. Molecules 2020, 25, 5450. [Google Scholar] [CrossRef]
  21. Nedolya, N.A.; Brandsma, L.; Trofimov, B.A. An Efficient Synthesis of 2-Trimethylsilyloxy-4-neopentyl quinoline via 3-Lithio-1-tert-butylallene and Phenyl Isocyanate. Mendeleev Commun. 1997, 7, 92. [Google Scholar] [CrossRef]
  22. Huang, Y.-N.; Li, Y.-L.; Li, J.; Deng, J. Beyond a Protecting Reagent: DMAP-Catalyzed Cyclization of Boc-Anhydride with 2-Alkenylanilines. J. Org. Chem. 2016, 81, 4645–4653. [Google Scholar] [CrossRef]
  23. Witulski, B.; Stengel, T. N-Functionalized 1-Alkynylamides: New Building Blocks for Transition Metal Mediated Inter- and Intramolecular [2+2+1] Cycloadditions. Angew. Chem. Int. Ed. 1998, 37, 489–492. [Google Scholar] [CrossRef]
  24. Iftikhar, R.; Mazhar, A.; Iqbal, M.S.; Khan, F.Z.; Askary, S.H.; Sibtain, H. Ring Forming Transformation of Ynamides via Cycloaddition. RSC. Adv. 2023, 13, 10715–10756. [Google Scholar] [CrossRef]
  25. Hu, Y.-C.; Zhao, Y.; Wan, B.; Chen, Q.-A. Reactivity of Ynamides in Catalytic Intermolecular Annulations. Chem. Soc. Rev. 2021, 50, 2582–2625. [Google Scholar] [CrossRef]
  26. Wang, X.-N.; Yeom, H.-S.; Fang, L.-C.; He, S.; Ma, Z.-X.; Kedrowski, B.L.; Hsung, R.P. Ynamides in Ring Forming Transformations. Acc. Chem. Res. 2014, 47, 560–578. [Google Scholar] [CrossRef]
  27. Evano, G.; Coste, A.; Jouvin, K. Ynamides: Versatile Tools in Organic Synthesis. Angew. Chem. In. Ed. 2010, 49, 2840–2859. [Google Scholar] [CrossRef]
  28. DeKorver, K.A.; Li, H.; Lohse, A.G.; Hayashi, R.; Lu, Z.; Zhang, Y.; Hsung, R.P. Ynamides: A Modern Functional Group for the New Millennium. Chem. Rev. 2010, 110, 5064–5106. [Google Scholar] [CrossRef]
  29. Lenko, I.; Alayrac, C.; Bożek, I.; Witulski, B. 1,3-Butadiynamides the Ethynylogous Ynamides: Synthesis, Properties and Applications in Heterocyclic Chemistry. Molecules 2023, 28, 4564. [Google Scholar] [CrossRef]
  30. Talbi, I.; Alayrac, C.; Lohier, J.-F.; Touil, S.; Witulski, B. Application of Ynamides in the Synthesis of 2-(Tosylamido)- and 2,5-Bis(tosylamido)thiophenes. Org. Lett. 2016, 18, 2656–2659. [Google Scholar] [CrossRef]
  31. Witulski, B.; Schweikert, T.; Schollmeyer, D.; Nemkovich, N.A. Synthesis and Molecular Properties of Donor-π-Spacer-Acceptor Ynamides with up to Four Conjugated Alkyne Units. Chem. Commun. 2010, 46, 2953–2955. [Google Scholar] [CrossRef]
  32. Lenko, I.; Mamontov, A.; Alayrac, C.; Legay, R.; Witulski, B. Media-Driven Pd-Catalyzed Reaction Cascades with 1,3-Diynamides Leading Selectively to Either Indoles or Quinolines. Angew. Chem. Int. Ed. 2021, 60, 22729–22734. [Google Scholar] [CrossRef]
  33. Witulski, B.; Alayrac, C.; Tevzadze-Saeftel, L. Palladium-Catalyzed Synthesis of 2-Aminoindoles by a Heteroanulation Reaction. Angew. Chem. Int. Ed. 2003, 42, 4257–4260. [Google Scholar] [CrossRef]
Molecules 29 03505 g001
Figure 1. Examples of biologically relevant 2-alkoxyquinoline derivatives.
Figure 1. Examples of biologically relevant 2-alkoxyquinoline derivatives.
Molecules 29 03505 g001
Molecules 29 03505 sch001
Scheme 1. (a) Pd-catalyzed cascade reaction of 1,3-butadiynamides 1 with primary or secondary amines 2 leading to 2-amino-4-alkenyl quinolines 4. (b) Pd-catalyzed cascade reaction of 1,3-butadiynamides 1 with primary alcohols 5 yielding 2-alkoxy-4-alkenyl quinolines 6.
Scheme 1. (a) Pd-catalyzed cascade reaction of 1,3-butadiynamides 1 with primary or secondary amines 2 leading to 2-amino-4-alkenyl quinolines 4. (b) Pd-catalyzed cascade reaction of 1,3-butadiynamides 1 with primary alcohols 5 yielding 2-alkoxy-4-alkenyl quinolines 6.
Molecules 29 03505 sch001
Molecules 29 03505 sch002
Scheme 2. Synthesis of 2-alkoxy-4-alkenylquinolines 6 and 2-alkoxy-4-dienylquinolines 7a,b.
Scheme 2. Synthesis of 2-alkoxy-4-alkenylquinolines 6 and 2-alkoxy-4-dienylquinolines 7a,b.
Molecules 29 03505 sch002
Molecules 29 03505 sch003
Scheme 3. Deuterium labeling experiment.
Scheme 3. Deuterium labeling experiment.
Molecules 29 03505 sch003
Molecules 29 03505 sch004
Scheme 4. Comparison of the 1H NMR (CDCl3, 500 MHz) spectra of quinolines 6a (top) and 8a (bottom). Only the δ = 6.2–8.2 ppm range is shown for reasons of clarity.
Scheme 4. Comparison of the 1H NMR (CDCl3, 500 MHz) spectra of quinolines 6a (top) and 8a (bottom). Only the δ = 6.2–8.2 ppm range is shown for reasons of clarity.
Molecules 29 03505 sch004
Molecules 29 03505 sch005
Scheme 5. Proposed mechanism for the synthesis of 2-alkoxy-4-alkenylquinolines 6 and 2-alkoxy-4-(1,3-dienyl)quinolines 7.
Scheme 5. Proposed mechanism for the synthesis of 2-alkoxy-4-alkenylquinolines 6 and 2-alkoxy-4-(1,3-dienyl)quinolines 7.
Molecules 29 03505 sch005
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Lenko, I.; Mamontov, A.; Alayrac, C.; Witulski, B. Pallado-Catalyzed Cascade Synthesis of 2-Alkoxyquinolines from 1,3-Butadiynamides. Molecules 2024, 29, 3505. https://doi.org/10.3390/molecules29153505

AMA Style

Lenko I, Mamontov A, Alayrac C, Witulski B. Pallado-Catalyzed Cascade Synthesis of 2-Alkoxyquinolines from 1,3-Butadiynamides. Molecules. 2024; 29(15):3505. https://doi.org/10.3390/molecules29153505

Chicago/Turabian Style

Lenko, Illia, Alexander Mamontov, Carole Alayrac, and Bernhard Witulski. 2024. "Pallado-Catalyzed Cascade Synthesis of 2-Alkoxyquinolines from 1,3-Butadiynamides" Molecules 29, no. 15: 3505. https://doi.org/10.3390/molecules29153505

Article Metrics

Back to TopTop